Anesthesia with no opioids will improve safety in patients with extreme obesity: a double blind randomised controlled study.
Not Applicable
Completed
- Conditions
- Health Condition 1: E889- Metabolic disorder, unspecified
- Registration Number
- CTRI/2024/01/061321
- Lead Sponsor
- Max Healthcare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 224
Inclusion Criteria
Eligible patients will include consented adult patients of either gender, between the age of 18 and 65; body mass index (BMI) between 40 and 60; planned for elective laparoscopic cholecystectomy under general anesthesia
Exclusion Criteria
Patients with preoperative chronic use of opioid or NSAID; allergy to bupivacaine; local skin infection at the injection site of USTAP (ultrasound guided subcostal transverse abdominis plane block); liver or renal insufficiency; psychiatric, or neurological disease; prior open abdominal surgery above T10 dermatome; patients converted to open surgery; and patients expected to be subjected to more tissue trauma will be excluded from the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Discharge readiness : DR in hoursTimepoint: Discharge readiness : DR in hours
- Secondary Outcome Measures
Name Time Method Assessment of OFA on discharge readiness, quality of recovery, opioid consumption and patient satisfactionTimepoint: At the time of discharge readiness